Statistics for Achilles Therapeutics plc (id:8440 ACHL)
Valuation metrics
Market cap
45.69M
Enterprise value
-46,683,944.00
Trailing P/E (ttm)
-0.61
Forward P/E
-0.57
PEG ratio
-0.57
Price/Sales (ttm)
Price/Book (mrq)
0.38
Enterprise Value/Revenue
Enterprise Value/EBITDA
0.71
Overview
Shares outstanding
41.09M
Float
20.83M
Shares short
159.24K
% Held by insiders
0.07%
% Held by institutions
0.62%
Average volume (10 days)
178.28K
Average volume (90 days)
Price summary
52-Week low
0.68
52-Week high
1.76
52-Week change
23.36%
Beta
1.34
50-Day moving average
0.94
200-Day moving average
0.93
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-26.82%
Return on equity
-44.22%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-65,899,000.00
Net income to common (ttm)
-63,967,000.00
Diluted EPS (ttm)
-1.59
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
95.11M
Total cash per share (mrq)
2.32
Total debt (mrq)
4.46M
Total Debt/Equity (mrq)
3.86
Current ratio (mrq)
824.20%
Book value per share (mrq)
2.81
Cash flow
Cash flow statement
-48,000,000.00
Levered free cash flow (LFCF)
-30,137,000.00